Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

More articles from 5.1 Airway Pharmacology and Treatment

  • Effects of phosphoinositide-3-kinase inhibitors on steroid-insensitive airway inflammation in poly(I:C) and allergen challenged mice
    Genki Kimura, Yuki Nishimoto, Keitaro Ueda, Takahiro Nakaoki, Takashi Masuko, Peter J. Barnes, Kazuhiro Ito, Yasuo Kizawa
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4896; DOI: 10.1183/13993003.congress-2016.PA4896
  • Neutrophils in bronchial mucosa, sputum and blood after administration of the CXCR2-antagonist AZD5069 - An explorative study in neutrophilic asthma
    Henrik Watz, Anne Kirsten, Frauke Pedersen, Torsten Goldmann, Florian Stellmacher, Mohib Uddin, Bengt Larsson, Gerhard Böttcher, Anna Malmgren, Marteen Kraan, Klaus Rabe
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4892; DOI: 10.1183/13993003.congress-2016.PA4892
  • The combination of TNF-α neutralization and dexamethasone treatment restored the corticosteroid responsiveness in tobacco smoking mice
    Yuki Nishimoto, Genki Kimura, Keitaro Ueda, Takahiro Nakaoki, Kazuhiro Ito, Yasuo Kizawa
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA5065; DOI: 10.1183/13993003.congress-2016.PA5065
  • Tiotropium reduces oral prednisone requirements while improving respiratory function in patients with severe persistent asthma
    Bashir Omarjee
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4904; DOI: 10.1183/13993003.congress-2016.PA4904
  • Monitoring local pulmonary cAMP levels: Combining precision cut lung slice (PCLS) and fluorescence resonance energy transfer (FRET) technologies in mice
    Martina Schmidt, Haoxio Zuo, Wilfred Jelco Poppinga, Viacheslav Nikolaev
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA5055; DOI: 10.1183/13993003.congress-2016.PA5055
  • Olodaterol attenuates bleomycin induced lung fibrosis in mice
    Franziska Herrmann, Stefan-Lutz Wollin, Florian Gantner, Eva Wex
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA5056; DOI: 10.1183/13993003.congress-2016.PA5056
  • Neurokinin-1 receptor antagonism for the treatment of cough in lung cancer
    Amelie Harle, Fiona Blackhall, Alex Molassiotis, Kim Holt, Rachel Dockry, Philip Russell, Katy Burns, Ryan Robinson, Mark Birrell, Maria Belvisi, Jaclyn Smith
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA5060; DOI: 10.1183/13993003.congress-2016.PA5060
  • Modulation of inflammation by benralizumab in eosinophilic airway disease
    Paul Newbold, Hao Liu, Tuyet-Hang Pham, Gautam Damera, Sriram Sridhar
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4902; DOI: 10.1183/13993003.congress-2016.PA4902
  • Effect of high, medium, and low molecular weight hyaluronan on inflammation and oxidative stress in an in vitro model of human nasal epithelial cells
    Giusy D. Albano, Anna Bonanno, Luca Cavalieri, Eleonora Ingrassia, Caterina Di Sano, Liboria Siena, Loredana Riccobono, Rosalia Gagliardo, Mirella Profita
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA5064; DOI: 10.1183/13993003.congress-2016.PA5064
  • RPL554, an inhaled PDE3/4 inhibitor, causes comparable bronchodilation to high dose nebulised salbutamol in asthmatics with fewer systemic effects
    Leif Bjermer, Johnston Stewart, Katharine Abbott-Banner, Kenneth Newman
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4905; DOI: 10.1183/13993003.congress-2016.PA4905

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 106

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society